Fairman Group »

Jazz Pharmaceuticals shares owned by Fairman Group

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by Fairman Group from 13F filings

Historical chart of Fairman Group investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by Fairman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by Fairman Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.9k 11 170.00

More positions owned by Fairman Group

Ishares Tr Core S&p500 Etf (IVV)
Accenture Plc Ireland Shs Class A (ACN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Essent (ESNT)
Ea Series Trust Strive 500 Etf (STRV)
W.R. Berkley Corporation (WRB)
Veeva Sys Cl A Com (VEEV)
Vanguard Index Fds Total Stk Mkt (VTI)
Blackrock Etf Trust Ii Ishares High Yie (HIMU)
Litman Gregory Fds Tr Imgp Dbi Managed (DBMF)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Msci Eafe Etf (EFA)
Vanguard Index Fds Large Cap Etf (VV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Fairman Group

Top funds holding Jazz Pharmaceuticals

Vanguard Group
BlackRock
Capital World Investors
Dimensional Fund Advisors
LSV Asset Management
Jpmorgan Chase & Co
Ameriprise Financial
State Street Corporation
Franklin Resources
EcoR1 Capital
Hanna Zanoni
Geode Capital Management
Bank of New York Mellon
GoldenTree Asset Management
Swedbank AB

View all funds holding Jazz Pharmaceuticals